TOVECIMIG
UNII YXM6C5LQ2H

Substance Identification & Data

This profile provides standardized clinical and technical data for Tovecimig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) YXM6C5LQ2H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2923284-73-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
YXM6C5LQ2H
CAS Registry Number
2923284-73-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TOVECIMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13128
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tovecimig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TOVECIMIG

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR) (HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB-VEGF .GAMMA.1-CHAIN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS)3 FUSION PROTEIN WITH IMMUNOGLOBULIN, ANTI-(HUMAN NOTCH LIGAND DLL4) (HUMAN MONOCLONAL MLCK-2 SINGLE-CHAIN VARIABLE REGION FRAGMENT VL-(GGGGS)4-VH), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB-VEGF .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-SCFVLH_L-KAPPA, ANTI-(HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A, VEGF-A, VEGF)) AND ANTI-(HOMO SAPIENS DLL4 (DELTA-LIKE 4)), HUMANIZED AND HOMO SAPIENS MONOCLONAL ANTIBODY; BISPECIFIC
TOVECIMIG [INN]